KDR and neoplasm: It is clear that the work described here is preliminary, in that significant amounts of antibody are not yet available and monoclonal antibodies have not been produced, so the effects on VEGFR phosphorylation, tumour angiogenesis, or even longer term analysis of the effects on tumour growth are yet to be deduced.